本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cogent Biosciences, Inc.

34.83
-3.6600-9.51%
成交量:579.91万
成交额:2.05亿
市值:56.53亿
市盈率:-16.12
高:38.00
开:37.78
低:34.35
收:38.49
52周最高:43.73
52周最低:3.72
股本:1.62亿
流通股本:1.43亿
量比:4.82
换手率:4.06%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
净资产收益率:-73.70%
总资产收益率:-32.93%
市净率:10.34
市盈率(LYR):-13.66

数据加载中...

2025/07/07

重要事件披露

Form 8-K - Current report
2025/06/11

重要事件披露

Form 8-K - Current report
2025/06/05

重要事件披露

Form 8-K - Current report
2025/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

重要事件披露

Form 8-K - Current report
2024/12/09

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report